CAS: 84-77-5; Didecyl Phthalate

上下游产品

1-Decanol Diethyl phthalate phthalic anhydride 1-bromo dodecane

癸基溴,邻苯二甲酸置于potassium Hydrogencarbonate体系中,用 N,N-二甲基甲酰胺 作为反应溶剂,化学反应 12.0H,反应生成 邻苯二甲酸二癸酯
参考文献:一种室温磷光苯甲酸酯类化合物的制备方法
标题:一种室温磷光苯甲酸酯类化合物的制备方法
摘要:本发明涉及一种室温磷光苯甲酸酯类化合物,并采用高效的一步法制备苯甲酸酯类化合物,从而使得制备得到的苯甲酸酯类化合物具有在室温下的明显磷光现象,从而拓展了苯甲酸酯类化合物的应用范围,可广泛应用于磷光材料中使用.

专利信息

专利号:US-11858953-B2
优先权日:2018-04-04
标 题:Compositions and methods for synthesis of phosphorylated molecules
发明人：CHAPUT JOHN; LIAO JEN-YU; BALA SAIKAT
权利人:UNIV CALIFORNIA
摘要:The invention provides compositions and methods for synthesis of phosphorylated organic compounds, including nucleoside triphosphates.

专利号:US-12312376-B2
优先权日:2020-01-24
标 题:Therapeutic double stranded RNA and methods for producing the same
发明人：EQUELS THOMAS K; ATODARIA VISHWAJEETSINH M; SCOTT VICTORIA G; STRAYER DAVID R; RODINO PETER W
权利人:AIM IMMUNOTECH INC
摘要:Disclosed is a method for the synthesis of a therapeutic double-stranded RNA (tdsRNA), comprising: a) synthesizing a first single-stranded RNA (first ssRNA) in a first synthesis reaction with PNPase as the only RNA polymerase; b) synthesizing a second single-stranded RNA (second ssRNA) in a second synthesis reaction with PNPase as the only RNA polymerase; and c) hybridizing the first ssRNA with the second ssRNA to form the tdsRNA; wherein step a) and step b) are performed in any order. Also disclosed is a product produced by the method.

专利号:US-6051743-A
优先权日:1992-12-17
标题 :Process for the preparation of predominantly unbranched higher primary alcohols
发明人：BAHRMANN HELMUT; DECKERS GREGOR; GREB WOLFGANG; HEYMANNS PETER; LAPPE PETER; MUELLER THOMAS; SZAMEITAT JUERGEN; WIEBUS ERNST
权利人:HOECHST AG
摘要:For the preparation of predominantly unbranched higher primary alcohols, olefins from the Fischer-Tropsch synthesis are reacted with hydrogen and carbon monoxide in the presence of water and a catalyst which is rhodium, in metallic form or as a compound, and a water-soluble phosphine. The reaction product obtained is hydrogenated. The water-soluble phosphines employed are compounds whose anion is a phosphine containing at least one sulfonated or carboxylated aromatic radical and whose cation is a quaternary ammonium or phosphonium ion.

专利号:US-4975441-A
优先权日:1988-03-23
标 题:Lactams, their synthesis and use in cosmetic compositions
发明人：GIBSON WALTER T
权利人:UNILEVER PATENT HOLDINGS
摘要:A composition suitable for topical application to mammalian skin or hair for inducing, maintaining or increasing hair growth comprises: (i) a chemical inhibitor of glycosidase activity chosen from lactams having the structure: where A<1> and A<6> are -H, -CH3, - @@0, -CH2OT or @@@0 A<1> and A<6> being the same or different, and at least one of which being the group: @ @@o in a lactam ring; and where Q is -OT min , -NHT min or a lactam linkage to A<1> or A<6>; the Q groups being the same or different, and at least one of which is involved in a lactam linkage; and where T is the same or different and is chosen from -H, -CpH2p+1 or a metal ion, T min is -H or -COCpH2p+1, and p is an integer of from 1 to 22; provided that: where any of the Q groups is -OT min or -NHT min , then that group or groups can be of either stereochemical configuration with respect to the plane of the ring; and (ii) a cosmetically acceptable vehicle for the chemical inhibitor. Certain novel lactams are also claimed.

专利号:US-2020330400-A1
优先权日:2016-03-16
标 题:Methods for the treatment of cancer using coenzyme q10 and fatty acid metabolism inhibitors
发明人：GESTA STEPHANE; DIERS ANNE R; DADALI-ABEL TULIN
权利人:BERG LLC
摘要:Presented herein are methods for the treatment of oncological disorders by the co-administration of CoQ10 compositions and at least one fatty acid metabolism inhibitor. In one embodiment, the CoQ10 compositions are lipid-containing compositions. The fatty acid metabolism inhibitor may be an inhibitor of fatty acid synthesis, storage, transport or degradation. The fatty acid metabolism inhibitor may also be a modulator of fatty acid structure, for example a fatty acid desaturase or elongase. The fatty acid inhibitor may inhibit any molecule involved in fatty acid metabolism, such as fatty acid synthase (FASN), carnitine palmitoyltransferase 1 (CPT-1), long-chain 3-ketoacyl-CoA thiolase, or stearoyl-CoA desaturase-1 (SCD-1). In embodiments, the fatty acid metabolism inhibitor may be C75, Etomoxir, trimetazidine or A939572.

专利号:US-10450525-B2
优先权日:2014-08-27
标题:Process for alaknolamide synthesis
发明人：SUEN YAT FAN; LIU JOANNE; SIMARD FRANCOIS; LEUNG YUEN TING ANITA
权利人:CHEVRON ORONITE CO
摘要:The present invention is directed to a process of making alkanolamides wherein the “agingâ€? time is reduced and the diethanol amide to ester ratio in the finished product is increased. Further provided is an additive composition comprising an alkanolamide which contains a reduced amount of DEA and BHEP.